News
According to Forbes, Micro Labs has sold over 350 crore tablets of Dolo-650 since the Covid-19 outbreak in 2020, earning revenues of Rs 400 crore in a year. Micro Labs sold about 7.5 crore strips ...
Prices of various formulations of empagliflozin and metformin hydrochloride were approved for companies including Cipla Ltd, Zydus Healthcare, Lupin Ltd, Intas Pharmaceuticals, Cadila Pharmaceuticals, ...
What began as a humorous comment quickly turned into a serious conversation. Manufactured by Micro Labs Limited, Dolo-650 contains 650 mg of paracetamol—higher than the commonly known 500 mg dose.
The ceiling price fixed prior to that was Rs 0.66 per gram. Price of only one product from Micro Labs has been considered for fixing the price, based on the market share regulation, and Rs 0.02 has ...
intuitive software and the backing of Hamilton’s renowned service and applications support makes the NIMBUS workstation an indispensable tool for budget- and space-constrained labs. Using proven ...
Added to the Zacks Rank #1 (Strong Buy) list this week, Super Micro Computer’s SMCI stock has become compelling among the tech sector as it looks to move past investigations into its accounting ...
Since then, many people tend to take Dolo-650, a paracetamol-based tablet manufactured by Bengaluru-based Micro Labs, even at the slightest sign of fever. Social media sparks a Dolo-650 safety debate ...
The Government has directed all companies to file a half-yearly return regarding delay in payments to micro and small enterprises beyond 45 days, a gazette notification said. As on March 26 ...
A graduate student who moved into a 77square-foot micro-apartment says she has found the minimalist lifestyle liberating. Lydia Rouka, 27, is an international graduate student in Seoul ...
Shares of server solutions provider Super Micro (NASDAQ:SMCI) fell 8.8% in the afternoon session after stocks pulled back (Nasdaq -1.5%, S&P 500 -1.2%) amid fresh concerns about trade tariffs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results